Carilex Medical (ROCO:7726) GF Score: 35/100 (As of Jul. 19, 2026) — 59% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7726 Carilex Medical Inc ROCO:7726
35 GF Score
Price NT$31.95
! 5 Warning Signs
View Full Analysis

What is Carilex Medical GF Score?

Carilex Medical ROCO:7726 35 GF Score is 35 as of Jul. 19, 2026, which is 59% above its 10-year median of 22.00. GuruFocus rates ROCO:7726 with a GF Score™ of 35/100. The stock has 5 warning signs investors should review.

Carilex Medical has the GF Score of 35, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 5/10
3. Growth Rank : 7/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Carilex Medical might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Carilex Medical  (ROCO:7726) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Carilex Medical GF Score Related Terms

ROCO:7726 vs ABT, SYK, MDT: GF Score Comparison

For the Medical Devices subindustry, Carilex Medical's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carilex Medical GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's GF Score distribution charts can be found below:

* The bar in red indicates where Carilex Medical's GF Score falls into.


ROCO:7726
35GF Score
Carilex Medical Inc ROCO:7726
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 35 mean?
Carilex Medical (ROCO:7726) has a GF Score of 35 as of Jul. 19, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Carilex Medical and its competitors. This is 59% above median its historical median of 22.00. Over the past decade, Carilex Medical's GF Score has ranged from 6.00 to 34.00.
Is Carilex Medical's GF Score too high?
Carilex Medical's current GF Score of 35 is 59% above median its 10-year median of 22.00. Over the past 10 years, this metric has ranged from a low of 6.00 to a high of 34.00. Overall, Carilex Medical has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's GF Score compare to ABT and SYK?
Carilex Medical's GF Score of 35 can be compared against companies in the Medical Devices & Instruments industry. Historically, Carilex Medical's own GF Score has ranged from 6.00 to 34.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Carilex Medical and its competitors. Carilex Medical's current GF Score is 35, which is 59% above median its own 10-year median of 22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current GF Score of 35. The current GF Score is 35, which is 59% above median its 10-year median of 22.00. Carilex Medical's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current GF Score is 35 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carilex Medical Business Description

Address No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
35GF Score

Get the complete analysis for ROCO:7726

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.95
Price